Skip to search.
 TSX Up 0.07% TSX Ventures Up 0.51%

Genomic Health Inc. (GHDX)

-NasdaqGS
26.05 Down 0.30(1.13%) 1:05PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:26.35
Open:26.15
Bid:26.06 x 100
Ask:26.14 x 100
1y Target Est:30.67
Beta:1.04623
Earnings Date:Nov 2 - Nov 6 (Est.)
Day's Range:25.50 - 26.55
52wk Range:23.00 - 37.74
Volume:96,647
Avg Vol (3m):205,449
Market Cap:846.23M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GHDXDown 1.13%846.23M
HOLXUp 0.44%10.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.76
Quarterly EPS Est (Sep-15) :-0.18
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback